Insights

Strategic Partnership Potential Affinia Therapeutics has a track record of forming strategic partnerships with companies like Forge Biologics for manufacturing clinical trial materials. This indicates a potential sales opportunity for companies offering complementary services or products in the biotechnology research sector.

Key Personnel Expansion The recent appointment of Rami Daoud as the Chief Business and Financial Officer showcases Affinia's focus on strengthening its leadership team. Sales development representatives could explore opportunities to engage with key decision-makers like Rami Daoud to present relevant solutions or collaborations.

Financial Growth & Investment Having raised significant funding rounds, including a $110 million Series B financing, Affinia Therapeutics demonstrates robust financial health and investor confidence. This financial stability presents a sales opportunity for financial service providers or investment firms looking to engage with a successful biotech company.

Public Listing Impact Affinia Therapeutics went public in January 2022, signaling a milestone in their growth trajectory. This development opens doors for sales professionals in areas like investor relations, financial services, or consulting to engage with a publicly listed company and explore partnership opportunities.

Physical Expansion & Capacity Needs With recent office expansions and the goal of securing scaled-up manufacturing capacity, Affinia Therapeutics shows a need for infrastructure and operational support. This presents a sales opportunity for companies providing services related to office design, lab equipment, or manufacturing solutions.

Affinia Therapeutics Tech Stack

Affinia Therapeutics uses 8 technology products and services including ETQ Reliance, NetSuite, Microsoft Excel, and more. Explore Affinia Therapeutics's tech stack below.

  • ETQ Reliance
    Data Quality Management
  • NetSuite
    E-commerce
  • Microsoft Excel
    Editors
  • Benchling
    Health Platform
  • UNIX
    Operating Systems
  • Greenhouse
    Recruitment Marketing
  • Apache
    Web Servers
  • Nginx
    Web Servers

Media & News

Affinia Therapeutics's Email Address Formats

Affinia Therapeutics uses at least 1 format(s):
Affinia Therapeutics Email FormatsExamplePercentage
FLast@affiniatx.comJDoe@affiniatx.com
93%
F-Last@affiniatx.comJ-Doe@affiniatx.com
4%
FMiddleLast@affiniatx.comJMichaelDoe@affiniatx.com
2%
FMLast@affiniatx.comJMDoe@affiniatx.com
1%

Frequently Asked Questions

Where is Affinia Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Affinia Therapeutics's main headquarters is located at 43 Foundry Ste 120 Waltham, Massachusetts 02453 US. The company has employees across 2 continents, including North AmericaEurope.

What is Affinia Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Affinia Therapeutics is a publicly traded company; the company's stock symbol is AFTX.

What is Affinia Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Affinia Therapeutics's official website is affiniatx.com and has social profiles on LinkedIn.

How much revenue does Affinia Therapeutics generate?

Minus sign iconPlus sign icon
As of October 2024, Affinia Therapeutics's annual revenue reached $15M.

What is Affinia Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Affinia Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Affinia Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2024, Affinia Therapeutics has approximately 66 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: R. M.Chief Scientific Officer: C. A.Chief Development Officer: L. R.. Explore Affinia Therapeutics's employee directory with LeadIQ.

What industry does Affinia Therapeutics belong to?

Minus sign iconPlus sign icon
Affinia Therapeutics operates in the Biotechnology Research industry.

What technology does Affinia Therapeutics use?

Minus sign iconPlus sign icon
Affinia Therapeutics's tech stack includes ETQ RelianceNetSuiteMicrosoft ExcelBenchlingUNIXGreenhouseApacheNginx.

What is Affinia Therapeutics's email format?

Minus sign iconPlus sign icon
Affinia Therapeutics's email format typically follows the pattern of . Find more Affinia Therapeutics email formats with LeadIQ.

How much funding has Affinia Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2024, Affinia Therapeutics has raised $110M in funding. The last funding round occurred on May 03, 2021 for $110M.

When was Affinia Therapeutics founded?

Minus sign iconPlus sign icon
Affinia Therapeutics was founded in 2019.
Affinia Therapeutics

Affinia Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

We are a team with decades of proven success in translating science from bench to bedside across many companies and medicines, in gene therapy and beyond. We are driven by a purpose: to make a lasting positive impact in the lives of people affected by devastating rare and prevalent diseases where the genetic cause is understood.

Our thesis is simple and our vision, clear: gene therapies have an immense potential to cure many diseases with a one-time dose, but they are limited by current delivery methods for the genetic payload. We formed Affinia Therapeutics to singularly focus on creating innovations that can expand the reach of gene therapies to more prevalent diseases. We're re-engineering adeno-associated virus serotype 9 (AAV9), a gene therapy delivery method that has shown promise but only in a small number of diseases. 

Our initial focus is on diseases of the heart and the nervous system, where we foresee a generational change in the treatment paradigm similar to what has happened in the treatment of cancers. This is because advances in science are identifying new genes associated with diseases of the heart and the nervous system, making a compelling case for genetic medicines. The heart and nervous system are also tissues where targeted delivery of the therapeutic genetic payload is currently inadequate. Our ART platform gives us an advantage to develop first-in-class or best-in-class product candidates.

As an early team member you will play a key role in setting our culture and values. You will be working alongside the founding management team who have a track record of success in the industry. The pace of work is dynamic, fast and fun. 

Our site includes:  State of the Art lab space & Equipment-
Healthy Cafe, Outdoor Patio, State of the Art Gym/Yoga Studio, Lounge ( Pool Table/ Golf Simulator ), Free/Plentiful Parking and More!

Join Us!

Section iconCompany Overview

Headquarters
43 Foundry Ste 120 Waltham, Massachusetts 02453 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
AFTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
51-200

Section iconFunding & Financials

  • $110M

    Affinia Therapeutics has raised a total of $110M of funding over 2 rounds. Their latest funding round was raised on May 03, 2021 in the amount of $110M.

  • $10M$50M

    Affinia Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $110M

    Affinia Therapeutics has raised a total of $110M of funding over 2 rounds. Their latest funding round was raised on May 03, 2021 in the amount of $110M.

  • $10M$50M

    Affinia Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.